217 related articles for article (PubMed ID: 30391941)
1. Camostat Mesilate, Pancrelipase, and Rabeprazole Combination Therapy Improves Epigastric Pain in Early Chronic Pancreatitis and Functional Dyspepsia with Pancreatic Enzyme Abnormalities.
Yamawaki H; Futagami S; Kaneko K; Agawa S; Higuchi K; Murakami M; Wakabayashi M; Sakasegawa N; Kodaka Y; Ueki N; Gudis K; Kawamoto C; Iwakiri K
Digestion; 2019; 99(4):283-292. PubMed ID: 30391941
[TBL] [Abstract][Full Text] [Related]
2. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan.
Yamawaki H; Futagami S; Kawagoe T; Maruki Y; Hashimoto S; Nagoya H; Sato H; Kodaka Y; Gudis K; Akamizu T; Sakamoto C; Iwakiri K
Neurogastroenterol Motil; 2016 Jul; 28(7):1037-47. PubMed ID: 26920949
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients.
Wakabayashi M; Futagami S; Yamawaki H; Tatsuguchi A; Kaneko K; Agawa S; Higuchi K; Sakasegawa N; Murakami M; Akimoto T; Kodaka Y; Ueki N; Gudis K; Kawamoto C; Akamizu T; Sakamoto C; Iwakiri K
PLoS One; 2018; 13(11):e0205165. PubMed ID: 30403664
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Functional Dyspepsia and Early Chronic Pancreatitis.
Futagami S; Yamawaki H; Agawa S; Ikeda G; Noda H; Kirita K; Higuchi K; Gudis K; Murakami M; Kodaka Y; Ueki N; Iwakiri K
J Nippon Med Sch; 2020 Mar; 87(1):2-6. PubMed ID: 31434841
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective?
Ashizawa N; Hashimoto T; Miyake T; Shizuku T; Imaoka T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Apr; 21(4):767-71. PubMed ID: 16677167
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease.
Sai JK; Suyama M; Kubokawa Y; Matsumura Y; Inami K; Watanabe S
J Gastroenterol; 2010 Mar; 45(3):335-41. PubMed ID: 19876587
[TBL] [Abstract][Full Text] [Related]
7. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor.
Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Sakamoto H; Kuramoto T; Kojima K; Sanomura M; Hoshimoto M; Higashino T; Itabashi T; Takada K; Sakaguchi M; Tominaga K; Kusano M; Higuchi K
J Gastroenterol Hepatol; 2018 Mar; 33(3):623-630. PubMed ID: 28865098
[TBL] [Abstract][Full Text] [Related]
8. A Randomized, Double-Blind, Pilot Study of the Effect of Famotidine on Acotiamide Treatment for Functional Dyspepsia.
Hojo M; Nagahara A; Asaoka D; Takeda T; Izumi K; Matsumoto K; Ueyama H; Shimada Y; Matsumoto K; Nojiri S; Watanabe S
Digestion; 2017; 96(1):5-12. PubMed ID: 28605740
[TBL] [Abstract][Full Text] [Related]
9. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
[TBL] [Abstract][Full Text] [Related]
10. Effect of Pancrelipase Therapy on Exocrine Pancreatic Insufficiency Symptoms and Coefficient of Fat Absorption Associated With Chronic Pancreatitis.
Barkin JA; Barkin JS
Pancreas; 2021 Feb; 50(2):176-182. PubMed ID: 33560089
[TBL] [Abstract][Full Text] [Related]
11. Epigastric pain syndrome accompanying pancreatic enzyme abnormalities was overlapped with early chronic pancreatitis using endosonography.
Hashimoto S; Futagami S; Yamawaki H; Kaneko K; Kodaka Y; Wakabayashi M; Sakasegawa N; Agawa S; Higuchi K; Akimoto T; Ueki N; Kawagoe T; Sato H; Nakatsuka K; Gudis K; Kawamoto C; Akamizu T; Sakamoto C; Iwakiri K
J Clin Biochem Nutr; 2017 Sep; 61(2):140-145. PubMed ID: 28955132
[TBL] [Abstract][Full Text] [Related]
12. Trypsin may be associated with duodenal eosinophils through the expression of PAR2 in early chronic pancreatitis and functional dyspepsia with pancreatic enzyme abnormalities.
Agawa S; Futagami S; Yamawaki H; Tsushima R; Higuchi K; Habiro M; Kawawa R; Kodaka Y; Ueki N; Watanabe Y; Gudis K; Ohashi R; Iwakiri K
PLoS One; 2022; 17(10):e0275341. PubMed ID: 36264979
[TBL] [Abstract][Full Text] [Related]
13. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS).
Hongo M; Harasawa S; Mine T; Sasaki I; Matsueda K; Kusano M; Hanyu N; Nakada K; Shibata C
J Gastroenterol Hepatol; 2012 Jan; 27(1):62-8. PubMed ID: 22004457
[TBL] [Abstract][Full Text] [Related]
14. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
15. Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome.
Altan E; Masaoka T; Farré R; Tack J
Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):533-44. PubMed ID: 23061703
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical characteristics, eating behaviors, and clinical symptoms following fat intake in functional dyspepsia with functional dyspepsia with pancreatic enzyme abnormalities between Singapore and Japan.
Futagami S; Kessoku T; Kasai Y; Higurashi T; Nakajima A; Agawa S; Yamawaki H; Habiro M; Ueki N; Sanada I; Yamamoto M; Watanabe Y; Yamato H; Yamamoto T; Takasaki Y; Ito K; Hojo M; Isayama H; Siah KTH; Gwee KA
J Gastroenterol Hepatol; 2022 Aug; 37(8):1525-1533. PubMed ID: 35501294
[TBL] [Abstract][Full Text] [Related]
17. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria.
Vanheel H; Carbone F; Valvekens L; Simren M; Tornblom H; Vanuytsel T; Van Oudenhove L; Tack J
Am J Gastroenterol; 2017 Jan; 112(1):132-140. PubMed ID: 27958284
[TBL] [Abstract][Full Text] [Related]
18. The effect of acotiamide on epigastric pain syndrome and postprandial distress syndrome in patients with functional dyspepsia.
Shinozaki S; Osawa H; Sakamoto H; Hayashi Y; Kawarai Lefor A; Yamamoto H
J Med Invest; 2016; 63(3-4):230-5. PubMed ID: 27644564
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)-results from the European phase 3 open-label safety trial.
Tack J; Pokrotnieks J; Urbonas G; Banciu C; Yakusevich V; Bunganic I; Törnblom H; Kleban Y; Eavis P; Tsuchikawa M; Miyagawa T
Neurogastroenterol Motil; 2018 Jun; 30(6):e13284. PubMed ID: 29315999
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of acotiamide in combination with esomeprazole for functional dyspepsia refractory to proton-pump inhibitor monotherapy.
Mayanagi S; Kishino M; Kitagawa Y; Sunamura M
Tohoku J Exp Med; 2014 Nov; 234(3):237-40. PubMed ID: 25382232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
